Requejo, C. C., Candela, M. O., Muñoz, C. G., Candel, M. G., Valverde, I. S., Sanz, E. U., & Salmerón, P. P. (2018). 5PSQ-022 Pharmacological cardioversion in patients with recent-onset atrial fibrillation at emergency department: Efficacy and safety of vernakalant. Eur J Hosp Pharm.
Citación estilo ChicagoRequejo, C Caballero, M Onteniente Candela, C Gallego Muñoz, M Gil Candel, I Salar Valverde, E Urbieta Sanz, and P Piñera Salmerón. "5PSQ-022 Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation At Emergency Department: Efficacy and Safety of Vernakalant." Eur J Hosp Pharm 2018.
Cita MLARequejo, C Caballero, et al. "5PSQ-022 Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation At Emergency Department: Efficacy and Safety of Vernakalant." Eur J Hosp Pharm 2018.